litlas
ログインアカウント作成

David M. Kaye

1974–2026 年に発表

別表記
David M Kaye
234
論文数
32,351
被引用数
104
h 指数
223
i10 指数

被引用数

David M. Kaye の年別被引用数1975 年: 被引用 2 件1976 年: 被引用 4 件1977 年: 被引用 4 件1978 年: 被引用 1 件1979 年: 被引用 1 件1980 年: 被引用 2 件1982 年: 被引用 1 件1984 年: 被引用 2 件1985 年: 被引用 1 件1990 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 2 件1995 年: 被引用 15 件1996 年: 被引用 38 件1997 年: 被引用 56 件1998 年: 被引用 50 件1999 年: 被引用 90 件2000 年: 被引用 90 件2001 年: 被引用 92 件2002 年: 被引用 72 件2003 年: 被引用 116 件2004 年: 被引用 92 件2005 年: 被引用 124 件2006 年: 被引用 110 件2007 年: 被引用 144 件2008 年: 被引用 174 件2009 年: 被引用 179 件2010 年: 被引用 178 件2011 年: 被引用 162 件2012 年: 被引用 234 件2013 年: 被引用 197 件2014 年: 被引用 232 件2015 年: 被引用 245 件2016 年: 被引用 240 件2017 年: 被引用 169 件2018 年: 被引用 218 件2019 年: 被引用 843 件2020 年: 被引用 975 件2021 年: 被引用 1,011 件2022 年: 被引用 899 件2023 年: 被引用 712 件2024 年: 被引用 1,224 件2025 年: 被引用 694 件2026 年: 被引用 16 件1981 年は被引用が無いため表示していません1983 年は被引用が無いため表示していません1986〜1989 年は被引用が無いため表示していません1991〜1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,185 件、この内訳の 22.6%中国: 引用元論文 1,142 件、この内訳の 8.1%イギリス: 引用元論文 966 件、この内訳の 6.8%オーストラリア: 引用元論文 921 件、この内訳の 6.5%ドイツ: 引用元論文 870 件、この内訳の 6.2%イタリア: 引用元論文 761 件、この内訳の 5.4%カナダ: 引用元論文 607 件、この内訳の 4.3%オランダ: 引用元論文 567 件、この内訳の 4%フランス: 引用元論文 402 件、この内訳の 2.8%スペイン: 引用元論文 392 件、この内訳の 2.8%日本: 引用元論文 338 件、この内訳の 2.4%ベルギー: 引用元論文 255 件、この内訳の 1.8%
0%22.6%その他 26.3%

機関

分野

  • Medicine69.5%
  • Biochemistry, Genetics and Molecular Biology17%
  • Neuroscience4.7%
  • Engineering3.5%
  • Nursing1.3%
  • Psychology0.8%
  • その他3.2%

トピック

  • Cardiovascular Function and Risk Factors6%
  • Heart Failure Treatment and Management3.8%
  • Heart Rate Variability and Autonomic Control3%
  • Gut microbiota and health2.8%
  • Atrial Fibrillation Management and Outcomes2.5%
  • Cardiac Imaging and Diagnostics2.1%
  • その他79.8%

共著者

全論文

検索で開く
  1. High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice

    著者: Francine Z. Marques, Erin Nelson, Po‐Yin Chu, Duncan Horlock, April Fiedler, Mark Ziemann, Jian Tan, Sanjaya Kuruppu, Niwanthi W. Rajapakse, Assam El‐Osta, Charles R. Mackay, David M. Kaye - Circulation 2016 被引用: 1,055

  2. Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease

    著者: David M. Kaye, Waled Shihata, Hamdi Jama, Kirill Tsyganov, Mark Ziemann, Helen Kiriazis, Duncan Horlock, Amrita Vijay, Beverly Giam, Antony Vinh, Chad Johnson, April Fiedler, D. Donner, Matthew Snelson, Melinda T. Coughlan, Sarah Phillips, Xiao‐Jun Du, Assam El‐Osta, Grant R. Drummond, Gavin Lambert, Tim D. Spector, Ana M. Valdes, Charles R. Mackay, Francine Z. Marques - Circulation 2020 被引用: 403

  3. Sex differences in heart failure

    著者: Carolyn S.P. Lam, Clare Arnott, A. Beale, Chanchal Chandramouli, Denise Hilfiker‐Kleiner, David M. Kaye, Bonnie Ky, Bernadet T. Santema, Karen Sliwa, Adriaan A. Voors - European Heart Journal 2019 被引用: 779

  4. Alcohol Abstinence in Drinkers with Atrial Fibrillation

    著者: Aleksandr Voskoboinik, Jonathan M. Kalman, Anurika De Silva, Thomas Nicholls, B. Costello, Shane Nanayakkara, Sandeep Prabhu, Dion Stub, Sonia Azzopardi, Donna Vizi, G. Wong, C. Nalliah, Hariharan Sugumar, Michael Wong, Emily Kotschet, David M. Kaye, Andrew J. Taylor, Peter M. Kistler - New England Journal of Medicine 2020 被引用: 427

  5. Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction

    著者: Sandeep Prabhu, Andrew J. Taylor, Ben Costello, David M. Kaye, A. McLellan, Aleksandr Voskoboinik, Hariharan Sugumar, S. Lockwood, Michael B. Stokes, B. Pathik, C. Nalliah, G. Wong, Sonia Azzopardi, S. Gutman, Geoffrey Lee, Jamie Layland, Justin A. Mariani, Liang‐Han Ling, Jonathan M. Kalman, Peter M. Kistler - Journal of the American College of Cardiology 2017 被引用: 629

  6. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction

    著者: Yu-Chen Wang, Yen Chin Koay, Calvin Pan, Zhiqiang Zhou, W.H. Wilson Tang, Jennifer Wilcox, Xinmin S. Li, Alexia Zagouras, Francine Z. Marques, Hooman Allayee, Federico E. Rey, David M. Kaye, John O’Sullivan, Stanley L. Hazen, Yang Cao, Aldons J. Lusis - Circulation Research 2024 被引用: 117

  7. Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy

    著者: Thomas H. Marwick, Rebecca H. Ritchie, Jonathan E. Shaw, David M. Kaye - Journal of the American College of Cardiology 2018 被引用: 367

  8. Sex Differences in Cardiovascular Pathophysiology

    著者: A. Beale, Philippe Meyer, Thomas H. Marwick, Carolyn S.P. Lam, David M. Kaye - Circulation 2018 被引用: 492

  9. Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial

    著者: Sanjiv J Shah, Barry A Borlaug, Eugene S Chung, Donald E Cutlip, Philippe Debonnaire, Peter S Fail, Qi Gao, Gerd Hasenfuß, Rami Kahwash, David M Kaye, Sheldon E Litwin, Philipp Lurz, Joseph M Massaro, Rajeev C Mohan, Mark J Ricciardi, Scott D Solomon, Aaron L Sverdlov, Vijendra Swarup, Dirk J van Veldhuisen, Sebastian Winkler, Martin B Leon, Joseph Akar, Jiro Ando, Toshihisa Anzai, Masanori Asakura, Steven Bailey, Anupam Basuray, Fabrice Bauer, Martin Bergmann, John Blair, Jeffrey Cavendish, Eugene Chung, Maja Cikes, Ira Dauber, Erwan Donal, Jean-Christophe Eicher, Peter Fail, James Flaherty, Xavier Freixa, Sameer Gafoor, Zachary Gertz, Robert Gordon, Marco Guazzi, Cesar Guerrero-Miranda, Deepak Gupta, Finn Gustafsson, Cyrus Hadadi, Emad Hakemi, Louis Handoko, Moritz Hass, Jorg Hausleiter, Christopher Hayward, Gavin Hickey, Scott Hummel, Imad Hussain, Richard Isnard, Chisato Izumi, Guillaume Jondeau, Elizabeth Juneman, Koichiro Kinugawa, Robert Kipperman, Bartek Krakowiak, Selim Krim, Joshua Larned, Gregory Lewis, Erik Lipsic, Anthony Magalski, Sula Mazimba, Jeremy Mazurek, Michele McGrady, Scott Mckenzie, Shamir Mehta, John Mignone, Hakim Morsli, Ajith Nair, Thomas Noel, James Orford, Kishan Parikh, Tiffany Patterson, Martin Penicka, Mark Petrie, Burkert Pieske, Martijn Post, Philip Raake, Alicia Romero, John Ryan, Yoshihiko Saito, Takafumi Sakamoto, Yasushi Sakata, Michael Samara, Kumar Satya, Andrew Sindone, Randall Starling, Jean-Noël Trochu, Bharathi Upadhya, Jan van der Heyden, Vanessa van Empel, Amit Varma, Amanda Vest, Tobias Wengenmayer ほか 4 名 - The Lancet 2022 被引用: 235

  10. Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea

    著者: Yogesh N.V. Reddy, David M. Kaye, M. Louis Handoko, Arno A. van de Bovenkamp, Ryan J. Tedford, Carson Keck, Mads J. Andersen, Kavita Sharma, Rishi Trivedi, Rickey E. Carter, Masaru Obokata, Frederik H. Verbrugge, Margaret M. Redfield, Barry A. Borlaug - JAMA Cardiology 2022 被引用: 151

  11. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial

    著者: Hamdi Jama, Dakota Rhys‐Jones, Michael Nakai, Chu K Yao, Rachel E. Climie, Yusuke Sata, Dovile Anderson, Darren J. Creek, Geoffrey A. Head, David M. Kaye, Charles R. Mackay, Jane G. Muir, Francine Z. Marques - Nature Cardiovascular Research 2023 被引用: 120

  12. The Gut Microbiome of Heart Failure With Preserved Ejection Fraction

    著者: A. Beale, Joanne A. O’Donnell, Michael Nakai, Shane Nanayakkara, Donna Vizi, Kaye Carter, Eliza Dean, Rosilene V. Ribeiro, Stephanie Yiallourou, M. Carrington, Francine Z. Marques, David M. Kaye - Journal of the American Heart Association 2021 被引用: 135

  13. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction

    著者: David Chieng, Hariharan Sugumar, Louise Segan, Caleb Tan, Donna Vizi, Shane Nanayakkara, Ahmed Al‐Kaisey, Joshua Hawson, Sandeep Prabhu, Aleksandr Voskoboinik, Sue Finch, Joseph B. Morton, Geoffrey Lee, Justin A. Mariani, André La Gerche, Andrew J. Taylor, Erin J. Howden, Peter M. Kistler, Jonathan M. Kalman, David M. Kaye, Liang‐Han Ling - JACC Heart Failure 2023 被引用: 104

  14. Beyond gut feelings: how the gut microbiota regulates blood pressure

    著者: Francine Z. Marques, Charles R. Mackay, David M. Kaye - Nature Reviews Cardiology 2017 被引用: 402

  15. Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure

    著者: Mandeep R. Mehra, Ivan Netuka, Nir Uriel, Jason N. Katz, Francis D. Pagani, Ulrich P. Jorde, Finn Gustafsson, Jean M. Connors, Peter Ivák, Jennifer Cowger, John Ransom, Aditya Bansal, Koji Takeda, Richa Agarwal, Mirnela Byku, Michael M. Givertz, Abbas Bitar, Shelley Hall, Daniel Zimpfer, J. David Vega, Manreet Kanwar, Omar Saeed, Daniel J. Goldstein, Rebecca Cogswell, Farooq H. Sheikh, Matthew Danter, Yuriy Pya, Anita Phancao, John Henderson, D. Crandall, Kartik S. Sundareswaran, Edward G. Soltesz, Jerry D. Estep, ARIES-HM3 Investigators, Scott Silvestry, Antone Tatooles, Nasir Siulemanjee, Brett C. Sheridan, Sanjeev Gulati, Eugene S. Chung, Clément Delmas, Carmelo A. Milano, Pierre Dos Santos, Pavan Atluri, Douglas Horstmanshof, David A. D’Alessandro, Sriram Nathan, Peter Eckman, Anelechi Anyanwu, Anna Mara Scandroglio, Alessandro Ortalda, Ezequiel Molina, Jacob Abraham, Sern Lim, Robert Adamson, Ashwin Ravichandran, Chris Hayward, William Hiesinger, John W. Entwistle, Jennifer Conway, Eric Adler, Jonathan Grinstein, Andreas Brieke, Mary Keebler, Jeffrey D. Alexis, Igor Gošev, Craig H. Selzman, David M. Kaye - JAMA 2023 被引用: 161

  16. Essential Hypertension Is Associated With Changes in Gut Microbial Metabolic Pathways: A Multisite Analysis of Ambulatory Blood Pressure

    著者: Michael Nakai, Rosilene V. Ribeiro, Bruce R. Stevens, Paul A. Gill, Rikeish R. Muralitharan, Stephanie Yiallourou, Jane G. Muir, M. Carrington, Geoffrey A. Head, David M. Kaye, Francine Z. Marques - Hypertension 2021 被引用: 114

  17. New-onset atrial fibrillation prediction: the HARMS2-AF risk score

    著者: Louise Segan, Rodrigo Cánovas, Shane Nanayakkara, David Chieng, Sandeep Prabhu, Aleksandr Voskoboinik, Hariharan Sugumar, Liang‐Han Ling, Geoff Lee, Joseph B. Morton, André La Gerche, David M. Kaye, Prashanthan Sanders, Jonathan M. Kalman, Peter M. Kistler - European Heart Journal 2023 被引用: 75

  18. High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus

    著者: Brian G. Drew, Stephen J. Duffy, Melissa F. Formosa, Alaina K. Natoli, Darren C. Henstridge, Sally A. Penfold, Walter G. Thomas, Nigora Mukhamedova, Barbora de Courten, Josephine M. Forbes, Felicia Y. T. Yap, David M. Kaye, Gerrit van Hall, Mark A. Febbraio, Bruce E. Kemp, Dmitri Sviridov, Gregory R. Steinberg, Bronwyn A. Kingwell - Circulation 2009 被引用: 459

  19. Hypothermic oxygenated perfusion (HOPE) safely and effectively extends acceptable donor heart preservation times: Results of the Australian and New Zealand trial

    著者: David C. McGiffin, Christina Kure, Peter S. Macdonald, P. Jansz, S. Emmanuel, Silvana Marasco, Atsuo Doi, Christopher Merry, Robert Larbalestier, Amit Shah, A. Geldenhuys, Amul Kumar Sibal, Cara A. Wasywich, Jacob Mathew, Eldho Paul, C. Cheshire, Angeline Leet, James Hare, Sandra E. Graham, John F. Fraser, David M. Kaye - The Journal of Heart and Lung Transplantation 2023 被引用: 83

  20. The impact of coffee subtypes on incident cardiovascular disease, arrhythmias, and mortality: long-term outcomes from the UK Biobank

    著者: David Chieng, Rodrigo Cánovas, Louise Segan, Hariharan Sugumar, Aleksandr Voskoboinik, Sandeep Prabhu, Liang‐Han Ling, Geoffrey Lee, Joseph B. Morton, David M. Kaye, Jonathan M. Kalman, Peter M. Kistler - European Journal of Preventive Cardiology 2022 被引用: 87

  21. Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology

    著者: A. Beale, Shane Nanayakkara, Louise Segan, Justin A. Mariani, Micha T. Maeder, Vanessa van Empel, Donna Vizi, Shona Evans, Carolyn S.P. Lam, David M. Kaye - JACC Heart Failure 2019 被引用: 135

  22. An evidence-based screening tool for heart failure with preserved ejection fraction: the HFpEF-ABA score

    著者: Yogesh N.V. Reddy, Rickey E. Carter, Varun Sundaram, David M. Kaye, M. Louis Handoko, Ryan J. Tedford, Mads J. Andersen, Kavita Sharma, Masaru Obokata, Frederik H. Verbrugge, Barry A. Borlaug - Nature Medicine 2024 被引用: 86

  23. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure

    著者: Barry A. Borlaug, John Blair, Martin W. Bergmann, Heiko Bugger, Dan Burkhoff, Leonhard Bruch, David S. Celermajer, Brian Claggett, John G.F. Cleland, Donald E. Cutlip, Ira Dauber, Jean-Christophe Eicher, Qi Gao, Thomas M. Gorter, Finn Gustafsson, Chris Hayward, Jan van der Heyden, Gerd Hasenfuß, Scott L. Hummel, David M. Kaye, Jan Komtebedde, Joseph M. Massaro, Jeremy A. Mazurek, Scott McKenzie, Shamir R. Mehta, Mark C. Petrie, Marco C. Post, Ajith Nair, Andreas Rieth, Frank E. Silvestry, Scott D. Solomon, Jean-Noël Trochu, Dirk J. Van Veldhuisen, Ralf Westenfeld, Martin B. Leon, Sanjiv J. Shah, on behalf of the REDUCE LAP-HF-II Investigators - Circulation 2022 被引用: 120

  24. Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis

    著者: Rajiv Mahajan, Michael B. Stokes, Adrian D. Elliott, D. Munawar, K. Khokhar, Anand Thiyagarajah, Jeroen Hendriks, Dominik Linz, Celine Gallagher, David M. Kaye, Dennis H. Lau, Prashanthan Sanders - Heart 2019 被引用: 117